Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of White Noise and Lullaby on Vital Signs of Term Newborns in Neonatal Intensive Care

12. mai 2026 oppdatert av: Başakşehir Çam & Sakura City Hospital

Comparison of the Effects of White Noise and Lullaby on Vital Parameters in Term Infants Hospitalized in the Neonatal Intensive Care Unit: A Controlled Randomized Study

This clinical study aims to evaluate how two types of gentle sounds - white noise and a traditional Turkish lullaby ("Dandini Dandini Dastana") - affect the vital signs of term newborns cared for in the Neonatal Intensive Care Unit (NICU).

The first weeks of life are critical for newborns, especially those who need special care in the NICU. During this time, maintaining physiological stability-such as normal heart rate, breathing rate, and oxygen levels-is essential. In addition to medical treatments, non-pharmacological interventions like music and soothing sounds are increasingly used to reduce stress and support comfort.

In this randomized controlled study, 70 term newborns (born after 37 weeks of gestation and weighing at least 2500 grams) were randomly assigned to one of two groups:

  • White Noise Group: infants listened to a digitally recorded white noise (imitating intrauterine sound patterns) for 20 minutes.
  • Lullaby Group: infants listened to a recording of the traditional lullaby "Dandini Dandini Dastana" for the same duration.

Both interventions were administered three times a day for four consecutive days in a calm NICU environment. The sound level was carefully calibrated not to exceed 55 decibels (dBA), ensuring safety for newborn hearing.

Researchers measured heart rate, respiratory rate, and oxygen saturation (SpO₂) at baseline and at the 5th, 10th, 15th, and 20th minutes during each session.

Results showed that both white noise and lullaby sessions led to a gradual decrease in heart rate, while breathing rate and oxygen levels remained stable. No adverse events or signs of physiological instability were observed.

These findings suggest that both white noise and lullaby listening are safe, low-cost, and effective supportive methods for helping term newborns remain calm and physiologically stable during intensive care. The study contributes to growing evidence that structured auditory stimulation can help promote comfort and self-regulation in newborns without the need for medication.

Studieoversikt

Detaljert beskrivelse

Background and Rationale: Newborns admitted to the Neonatal Intensive Care Unit (NICU) are frequently exposed to environmental stressors that may disrupt autonomic stability. Developmental care strategies increasingly incorporate sensory modulation approaches to support physiological regulation. Auditory stimulation, including white noise and lullabies, has shown potential to reduce stress responses and promote behavioral organization. However, comparative evidence in term newborns remains limited, as most studies have focused on preterm populations. This study was designed to evaluate and compare the short-term physiological effects of two standardized auditory interventions-white noise and lullaby exposure-in term newborns under controlled NICU conditions.

Study Design and Setting: This was a prospective, multicenter, parallel-group randomized controlled trial conducted in two tertiary NICUs in Türkiye. Participants were randomized in a 1:1 ratio using stratified block randomization by center, with allocation concealment ensured through sealed opaque envelopes.

Intervention Protocols: Both interventions were delivered in a standardized manner to minimize environmental variability. Auditory stimulation sessions lasted 20 minutes and were administered three times daily over four consecutive days. Sound intensity was calibrated prior to each session and maintained below 55 dBA to ensure auditory safety. White noise exposure consisted of a digitally standardized recording simulating intrauterine acoustic patterns. The lullaby intervention consisted of a culturally familiar, standardized digital recording. All sessions were conducted during stable clinical conditions and scheduled to avoid routine caregiving activities. The playback device was a portable MP3 player with a 3-5 W speaker placed approximately 50 cm from the infant's ear. Sound intensity was measured before each session using a Wintact WT85 decibel meter, maintaining a maximum of 55 dBA (A-weighted). Sessions were conducted during quiet periods after routine care and feeding to minimize external stressors.

Data Collection and Measurements: Physiological parameters were obtained using continuous bedside monitoring systems. Heart rate and oxygen saturation were automatically recorded, while respiratory rate was assessed using standardized observation methods. Repeated measurements within sessions enabled evaluation of temporal trends and within-subject variability.

Statistical Analysis: The primary analytical approach utilized linear mixed-effects models to account for repeated measurements within individuals. Fixed effects included intervention group, time, and group-by-time interaction, while random intercepts accounted for within-subject correlation. Baseline values and study center were included as covariates. Sensitivity analyses were performed to assess the robustness of the findings.

Ethical Considerations: The study was approved by the institutional ethics committee, and written informed consent was obtained from parents or legal guardians prior to enrollment. All procedures were conducted in accordance with the Declaration of Helsinki.

Studietype

Intervensjonell

Registrering (Faktiske)

70

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Istanbul, Tyrkia (Türkiye)
        • Başakşehir Çam and Sakura City Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Gestational age ≥ 37 completed weeks
  • Birth weight ≥ 2500 grams
  • Postnatal age between 0 and 28 days at enrollment
  • Admitted to the neonatal intensive care unit (NICU) for any medical reason
  • Spontaneous breathing (not intubated)
  • No current sedative or analgesic medication
  • Written informed consent obtained from parents or legal guardians

Exclusion Criteria:

  • Gestational age < 37 weeks (preterm infants)
  • Birth weight < 2500 grams
  • Congenital hearing loss or major congenital anomaly
  • History of seizures or intracranial hemorrhage
  • Requirement for mechanical ventilation
  • Current use of sedative or analgesic drugs
  • Early discharge or death before completion of the intervention protocol
  • Parental refusal or withdrawal of consent during study procedures

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: White Noise Group
Term newborns received a standardized white noise recording representing intrauterine sound characteristics ("Colic" album, Osman Orhan). Each session lasted 20 minutes, conducted three times daily (at 11:00, 14:00, and 17:00) for four consecutive days. The sound level was calibrated to a maximum of 55 dBA at the infant's ear level. Heart rate, respiratory rate, and oxygen saturation were recorded at baseline and at the 5th, 10th, 15th, and 20th minutes during each session.
Participants listened to a digitally recorded standardized white noise stimulus mimicking intrauterine sound characteristics. Each session lasted 20 minutes and was conducted three times daily (at 11:00, 14:00, and 17:00) for four consecutive days in the neonatal intensive care unit. The sound level was measured and calibrated before each session to a maximum of 55 dBA at the infant's ear level using a decibel meter (Wintact WT85). Heart rate, respiratory rate, and oxygen saturation were monitored at baseline and during the session. The intervention was administered under stable clinical conditions after routine care.
Eksperimentell: Lullaby Group
Term newborns listened to a digital recording of the traditional Turkish lullaby "Dandini Dandini Dastana." Each session lasted 20 minutes, conducted three times daily (at 11:00, 14:00, and 17:00) for four consecutive days, under identical environmental conditions as the white noise group. The sound intensity was standardized not to exceed 55 dBA. Vital signs (heart rate, respiratory rate, oxygen saturation) were monitored at baseline and throughout the session.
Participants listened to a digital recording of the traditional Turkish lullaby "Dandini Dandini Dastana." Sessions lasted 20 minutes and were conducted three times daily (11:00, 14:00, 17:00) for four consecutive days in the neonatal intensive care unit, identical to the white noise schedule. The sound intensity was standardized to a maximum of 55 dBA. Vital parameters (heart rate, respiratory rate, oxygen saturation) were recorded at baseline and at 5, 10, 15, and 20 minutes during each session. The intervention aimed to promote relaxation and physiological stability in term newborns.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Heart Rate (beats per minute) from Baseline to 20th Minute During Intervention Session
Tidsramme: Change from baseline to 20 minutes, averaged across intervention sessions over 4 days.
Heart rate (beats per minute) was continuously monitored using bedside patient monitors (Dräger, Germany). The primary endpoint is the within-session change in heart rate from baseline to the 20th minute, averaged across all sessions over four days. The measure assesses the acute physiological calming effect of auditory stimulation (white noise or lullaby) in term newborns.
Change from baseline to 20 minutes, averaged across intervention sessions over 4 days.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Oxygen Saturation (SpO₂, %) from Baseline to 20th Minute During Intervention Session
Tidsramme: Change from baseline to 20 minutes, averaged across intervention sessions over 4 days.
Peripheral oxygen saturation (SpO₂, %) was continuously recorded using pulse oximetry as part of bedside monitoring. The outcome assesses maintenance of oxygenation and physiological safety during auditory stimulation in term newborns.
Change from baseline to 20 minutes, averaged across intervention sessions over 4 days.
Incidence of Adverse Events During or Immediately After Intervention Sessions
Tidsramme: During intervention and up to 30 minutes post-intervention, over 4 days.
Any clinically significant event (e.g., desaturation, apnea, bradycardia, or need for clinical intervention) occurring during or immediately after a session was documented according to NICU safety protocols. This outcome assesses the tolerability and safety of auditory stimulation.
During intervention and up to 30 minutes post-intervention, over 4 days.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Nevin Cambaz Kurt, MD, Assoc. Prof., TC Health Sciences University, Basaksehir Cam and Sakura City Hospital

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

30. september 2025

Primær fullføring (Faktiske)

20. desember 2025

Studiet fullført (Faktiske)

20. desember 2025

Datoer for studieregistrering

Først innsendt

29. desember 2025

Først innsendt som oppfylte QC-kriteriene

12. mai 2026

Først lagt ut (Faktiske)

15. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

15. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. mai 2026

Sist bekreftet

1. desember 2025

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data (IPD) will not be shared due to the inclusion of neonatal participants and the sensitive nature of clinical data collected in intensive care settings. Only aggregated, de-identified summary data will be reported in publications and conference presentations. Data sharing beyond these summaries is restricted by institutional ethics approval and parental consent limitations.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere